These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20422332)

  • 1. Development and evaluation of hydrophilic colloid matrix of famotidine tablets.
    Shoaib MH; Al Sabah Siddiqi S; Yousuf RI; Zaheer K; Hanif M; Rehana S; Jabeen S
    AAPS PharmSciTech; 2010 Jun; 11(2):708-18. PubMed ID: 20422332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development and in-vitro evaluation of metoprolol tartrate tablets containing xanthan-tragacanth.
    Rasul A; Iqbal M; Murtaza G; Waqas MK; Hanif M; Khan SA; Bhatti NS
    Acta Pol Pharm; 2010; 67(5):517-22. PubMed ID: 20873420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation development and in-vitro evaluation of gastroretentive drug delivery system of loxoprofen sodium: A natural excipients based approach.
    Zaman M; Akhtar F; Baseer A; Hasan SMF; Aman W; Khan A; Badshah M; Majeedullah -
    Pak J Pharm Sci; 2021 Jan; 34(1):57-63. PubMed ID: 34248003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
    Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation development and evaluation of Diltiazem HCl sustained release matrix tablets using HPMC K4M and K100M.
    Qazi F; Shoaib MH; Yousuf RI; Qazi TM; Mehmood ZA; Hasan SM
    Pak J Pharm Sci; 2013 Jul; 26(4):653-63. PubMed ID: 23811439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and in vitro evaluation of sustained release matrix tablets using cross-linked natural gum.
    Jamil QA; Masood MI; Jamil MN; Masood I; Iqbal SM
    Pak J Pharm Sci; 2017 Mar; 30(2):355-362. PubMed ID: 28649056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physico-chemical comparison of famotidine tablets prepared via dry granulation and direct compression techniques.
    Baseer A; Hassan F; Hassan SF; Jabeen S; Israr F; Murtaza G; Haque N
    Pak J Pharm Sci; 2013 May; 26(3):439-43. PubMed ID: 23625414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-daily sustained-release matrix tablets of nicorandil: formulation and in vitro evaluation.
    Reddy KR; Mutalik S; Reddy S
    AAPS PharmSciTech; 2003 Dec; 4(4):E61. PubMed ID: 15198556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and assessment of controlled release tablets of famotidine by using eudragit RL 100 polymer.
    Rabani T; Umer Jan S; Razaque G; Gul R; Ahmad Khan K; Rashid F; Tufail M
    Pak J Pharm Sci; 2022 Nov; 35(6(Special)):1779-1786. PubMed ID: 36861243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Hydrophilic Matrix Tablets for the Controlled Released of Chlorzoxazone.
    Creteanu A; Lisa G; Vasile C; Popescu MC; Pamfil D; Lungu CN; Panainte AD; Tantaru G
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of gastroretentive sustained release tablets prepared by combination of melt/sublimation actions of L-menthol and penetration of molten polymers into tablets.
    Fukuda M; Goto A
    Chem Pharm Bull (Tokyo); 2011; 59(10):1221-6. PubMed ID: 21963630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre and post characterization of ODTs with emphasis on compression force and quality of super-disintegrants: In vivo analysis in healthy volunteers.
    Ayub S; Hanif S; Ul Huq UI; Irfan M; Ali I; Madkhali OA; Farzana K; Ali Syed M; Shahid N; Aftab T; Asmatullah M
    Pak J Pharm Sci; 2023 Nov; 36(6):1767-1775. PubMed ID: 38124417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug release-modulating mechanism of hydrophilic hydroxypropylmethylcellulose matrix tablets: distribution of atoms and carrier and texture analysis.
    Park JB; Lim J; Kang CY; Lee BJ
    Curr Drug Deliv; 2013 Dec; 10(6):732-41. PubMed ID: 23855499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development of directly compressible mebevarine tablets using superdisintegrant: A way to investigate quality atributes, in vitro release kinetics and stability profile.
    Siddiqui S; Naqvi GR; Ali H; Zafar F; Siddiqui S; Nawab A; Siddiqui T
    Pak J Pharm Sci; 2021 May; 34(3):915-924. PubMed ID: 34602414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
    Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
    Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Approach to Enhance the Solubility of Famotidine Tablet by Using Naturally Isolated Pear Starch.
    Anjali K; Manjul SP
    Recent Pat Drug Deliv Formul; 2018; 12(1):75-80. PubMed ID: 29303081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation development and comparative in vitro study of metoprolol tartrate (IR) tablets.
    Husain T; Shoaib MH; Yousuf RI; Maboos M; Khan M; Bashir L; Naz S
    Pak J Pharm Sci; 2016 May; 29(3):853-60. PubMed ID: 27166530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
    Jhawat V; Gupta S; Saini V
    Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desktop 3D printing of controlled release pharmaceutical bilayer tablets.
    Khaled SA; Burley JC; Alexander MR; Roberts CJ
    Int J Pharm; 2014 Jan; 461(1-2):105-11. PubMed ID: 24280018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.